Literature DB >> 27833939

Probabilistic Reinforcement Learning in Patients With Schizophrenia: Relationships to Anhedonia and Avolition.

Erin C Dowd1, Michael J Frank2, Anne Collins3, James M Gold4, Deanna M Barch5.   

Abstract

BACKGROUND: Anhedonia (a reduced experience of pleasure) and avolition (a reduction in goal-directed activity) are common features of schizophrenia that have substantial effects on functional outcome, but are poorly understood and treated. Here, we examined whether alterations in reinforcement learning may contribute to these symptoms in schizophrenia by impairing the translation of reward information into goal-directed action.
METHODS: 38 stable outpatients with schizophrenia or schizoaffective disorder and 37 healthy controls underwent fMRI during a probabilistic stimulus selection reinforcement learning task with dissociated choice- and feedback-related activation, followed by a behavioral transfer task allowing separate assessment of learning from positive versus negative outcomes. A Q-learning algorithm was used to examine functional activation relating to prediction error at the time of feedback and to expected value at the time of choice.
RESULTS: Behavioral results suggested a reduction in learning from positive feedback in patients; however, this reduction was unrelated to anhedonia/avolition severity. On fMRI analysis, prediction error-related activation at the time of feedback was highly similar between patients and controls. During early learning, patients activated regions in the cognitive control network to a lesser extent than controls. Correlation analyses revealed reduced responses to positive feedback in dorsolateral prefrontal cortex and caudate among those patients higher in anhedonia/avolition.
CONCLUSIONS: Together, these results suggest that anhedonia/avolition are as strongly related to cortical learning or higher-level processes involved in goal-directed behavior such as effort computation and planning as to striatally mediated learning mechanisms.

Entities:  

Keywords:  Motivation; anhedonia; prediction error; reinforcement learning; schizophrenia; striatum

Year:  2016        PMID: 27833939      PMCID: PMC5098503          DOI: 10.1016/j.bpsc.2016.05.005

Source DB:  PubMed          Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging        ISSN: 2451-9022


  43 in total

1.  Habit and skill learning in schizophrenia: evidence of normal striatal processing with abnormal cortical input.

Authors:  Thomas W Weickert; Alejandro Terrazas; Llewellyn B Bigelow; James D Malley; Thomas Hyde; Michael F Egan; Daniel R Weinberger; Terry E Goldberg
Journal:  Learn Mem       Date:  2002 Nov-Dec       Impact factor: 2.460

Review 2.  Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research.

Authors:  Julie W Messinger; Fabien Trémeau; Daniel Antonius; Erika Mendelsohn; Vasthie Prudent; Arielle D Stanford; Dolores Malaspina
Journal:  Clin Psychol Rev       Date:  2010-09-18

3.  Relative risk of probabilistic category learning deficits in patients with schizophrenia and their siblings.

Authors:  Thomas W Weickert; Terry E Goldberg; Michael F Egan; Jose A Apud; Martijn Meeter; Catherine E Myers; Mark A Gluck; Daniel R Weinberger
Journal:  Biol Psychiatry       Date:  2010-02-20       Impact factor: 13.382

4.  The NIMH-MATRICS consensus statement on negative symptoms.

Authors:  Brian Kirkpatrick; Wayne S Fenton; William T Carpenter; Stephen R Marder
Journal:  Schizophr Bull       Date:  2006-02-15       Impact factor: 9.306

5.  Expected value and prediction error abnormalities in depression and schizophrenia.

Authors:  Victoria B Gradin; Poornima Kumar; Gordon Waiter; Trevor Ahearn; Catriona Stickle; Marteen Milders; Ian Reid; Jeremy Hall; J Douglas Steele
Journal:  Brain       Date:  2011-04-10       Impact factor: 13.501

6.  A mechanistic account of striatal dopamine function in human cognition: psychopharmacological studies with cabergoline and haloperidol.

Authors:  Michael J Frank; Randall C O'Reilly
Journal:  Behav Neurosci       Date:  2006-06       Impact factor: 1.912

7.  Typical and atypical antipsychotic medications differentially affect two nondeclarative memory tasks in schizophrenic patients: a double dissociation.

Authors:  Richard J Beninger; James Wasserman; Katherine Zanibbi; Danielle Charbonneau; Jennifer Mangels; Bruce V Beninger
Journal:  Schizophr Res       Date:  2003-06-01       Impact factor: 4.939

8.  Altered reward functions in patients on atypical antipsychotic medication in line with the revised dopamine hypothesis of schizophrenia.

Authors:  Henrik Walter; Hannes Kammerer; Karel Frasch; Manfred Spitzer; Birgit Abler
Journal:  Psychopharmacology (Berl)       Date:  2009-06-12       Impact factor: 4.530

Review 9.  Multiple dopamine functions at different time courses.

Authors:  Wolfram Schultz
Journal:  Annu Rev Neurosci       Date:  2007       Impact factor: 12.449

10.  Striatal dysfunction during reversal learning in unmedicated schizophrenia patients.

Authors:  Florian Schlagenhauf; Quentin J M Huys; Lorenz Deserno; Michael A Rapp; Anne Beck; Hans-Joachim Heinze; Ray Dolan; Andreas Heinz
Journal:  Neuroimage       Date:  2013-11-27       Impact factor: 6.556

View more
  41 in total

1.  Clarifying the overlap between motivation and negative symptom measures in schizophrenia research: A meta-analysis.

Authors:  Lauren Luther; Melanie W Fischer; Ruth L Firmin; Michelle P Salyers
Journal:  Schizophr Res       Date:  2018-12-19       Impact factor: 4.939

2.  Predictive Modulation of Corticospinal Excitability and Implicit Encoding of Movement Probability in Schizophrenia.

Authors:  Lucile Dupin; Loïc Carment; Laura Guedj; Macarena Cuenca; Marie-Odile Krebs; Marc A Maier; Isabelle Amado; Påvel G Lindberg
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

Review 3.  Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research.

Authors:  Maria R Dauvermann; Graham Lee; Neil Dawson
Journal:  Br J Pharmacol       Date:  2017-08-11       Impact factor: 8.739

4.  From neuroimaging to daily functioning: A multimethod analysis of reward anticipation in people with schizophrenia.

Authors:  Erin K Moran; Adam J Culbreth; Sridhar Kandala; Deanna M Barch
Journal:  J Abnorm Psychol       Date:  2019-08-29

5.  Deficits in reinforcement learning but no link to apathy in patients with schizophrenia.

Authors:  Matthias N Hartmann-Riemer; Steffen Aschenbrenner; Magdalena Bossert; Celina Westermann; Erich Seifritz; Philippe N Tobler; Matthias Weisbrod; Stefan Kaiser
Journal:  Sci Rep       Date:  2017-01-10       Impact factor: 4.379

6.  Meta-analytic evidence for altered mesolimbic responses to reward in schizophrenia.

Authors:  Henry W Chase; Polina Loriemi; Tobias Wensing; Simon B Eickhoff; Thomas Nickl-Jockschat
Journal:  Hum Brain Mapp       Date:  2018-03-24       Impact factor: 5.038

7.  Computational Psychiatry and the Challenge of Schizophrenia.

Authors:  John H Krystal; John D Murray; Adam M Chekroud; Philip R Corlett; Genevieve Yang; Xiao-Jing Wang; Alan Anticevic
Journal:  Schizophr Bull       Date:  2017-05-01       Impact factor: 9.306

8.  Interactions Among Working Memory, Reinforcement Learning, and Effort in Value-Based Choice: A New Paradigm and Selective Deficits in Schizophrenia.

Authors:  Anne G E Collins; Matthew A Albrecht; James A Waltz; James M Gold; Michael J Frank
Journal:  Biol Psychiatry       Date:  2017-05-31       Impact factor: 13.382

9.  Nonsocial and social cognition in schizophrenia: current evidence and future directions.

Authors:  Michael F Green; William P Horan; Junghee Lee
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

10.  Impaired Expected Value Computations in Schizophrenia Are Associated With a Reduced Ability to Integrate Reward Probability and Magnitude of Recent Outcomes.

Authors:  Dennis Hernaus; Michael J Frank; Elliot C Brown; Jaime K Brown; James M Gold; James A Waltz
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.